Try our Advanced Search for more refined results

Genomic Health Investor Calls Exact Sciences Merger Unfair

By McCord Pagan ( June 30, 2020, 9:08 PM EDT) -- A former Genomic Health Inc. investor blasted the company's planned $2. 8 billion merger last year with fellow cancer treatment developer Exact Sciences Corp. as a sweetheart deal that undervalued the company, failed to disclose important information to investors and was agreed to by the controlling shareholder before terms were finalized. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies